China Action on Spine and Hip Status

NCT01758770 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3457

Last updated 2018-03-06

No results posted yet for this study

Summary

1. To determine the prevalences of osteoporotic fracture in elderly Chinese population.
2. To determine the prevalences of osteoporosis in elderly Chinese population using QCT BMD measurement.
3. To investigate the difference in the prevalences of osteoporosis between cities and urban-rural area in China.
4. To investigate the association of body composition with osteoporosis
5. To investigate the prevalence of liver steatosis in China
6. To investigate the application of QCT fat measurement

Conditions

Sponsors & Collaborators

  • Fu Wai Hospital, Beijing, China

    collaborator OTHER
  • University of California, San Francisco

    collaborator OTHER
  • Beijing Shi Jing Shan hospital,Beijing, China

    collaborator UNKNOWN
  • Tai yuan central hospital,taiyuan, shanxi

    collaborator UNKNOWN
  • Cheng Du Da Yi hospital,Cheng du, Sichuan

    collaborator UNKNOWN
  • Shen Yang 4th hospital,shen yang, liaoning

    collaborator UNKNOWN
  • Second hospital of sichuan university,Cheng du, Sichuan

    collaborator UNKNOWN
  • Chang Zhou Wu Jin Traditional Chinese Medicine hospital

    collaborator UNKNOWN
  • Red cross hospital of Shaanxi

    collaborator UNKNOWN
  • No 1 TCM hospital of Jiangsu

    collaborator UNKNOWN
  • No 2 TCM hospital of Jiangsu

    collaborator UNKNOWN
  • Chengdu Second people's hospital

    collaborator UNKNOWN
  • Affiliate hospital of jiangxi Traditional Chinese Medicine university

    collaborator UNKNOWN
  • Beijing Jishuitan Hospital

    lead OTHER

Principal Investigators

  • xiaoguang cheng, MD · Beijing ji shui tan hospital

Eligibility

Min Age
29 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2017-07-26
Completion
2017-07-26

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01758770 on ClinicalTrials.gov